container into the open mouth of subjects. After the administration,
Sponsors
Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence study
Bioequivalence study
LevetiracetamBioequivalence study
Bioequivalence study
Rosuvastatin
Phase 1
Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Levetiracetam film-coated tablets (500 mg) relative to KEPPRA® 500 MG (FILM-COATED TABLETS) (Original Levetiracetam film-coated tablets (500 mg)) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20200611001
Start: 2020-07-21Target: 24Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rosuvastatin 20 mg film-coated tablets relative to Crestor 20 mg tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20200617004
Start: 2020-09-08Target: 36Updated: 2026-03-30